Abiomed, Inc.
Abiomed, Inc. (ABMD) Stock Overview
Explore Abiomed, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
17.2B
P/E Ratio
126.85
EPS (TTM)
$5.83
ROE
0.10%
ABMD Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Abiomed, Inc. (ABMD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $485.83.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 126.85 and a market capitalization of 17.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.